UBS ASSET MANAGEMENT AMERICAS LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 156 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$118,0270.0%84,9120.0%0.00%
Q1 2023$118,027
-30.2%
84,9120.0%0.00%
Q4 2022$168,975
-99.9%
84,9120.0%0.00%
Q3 2022$171,523,000
-45.5%
84,912
-14.2%
0.00%
Q2 2022$314,773,000
-23.7%
98,9850.0%0.00%
Q1 2022$412,767,000
-12.9%
98,9850.0%0.00%
Q4 2021$474,139,000
-10.3%
98,9850.0%0.00%
Q3 2021$528,580,000
+4.3%
98,9850.0%0.00%
Q2 2021$506,804,000
-13.4%
98,985
+13.8%
0.00%
Q1 2021$585,166,000
+42.9%
86,949
-3.0%
0.00%
Q4 2020$409,495,000
-7.8%
89,605
-21.8%
0.00%
Q3 2020$444,314,000
-18.5%
114,5140.0%0.00%
Q2 2020$545,087,000
+34.2%
114,514
-1.9%
0.00%
Q1 2020$406,213,000
-1.5%
116,728
+36.5%
0.00%
Q4 2019$412,289,000
+33.5%
85,537
-19.7%
0.00%
Q3 2019$308,781,000
-52.5%
106,476
+17.4%
0.00%
Q2 2019$650,368,000
-20.4%
90,707
+57.3%
0.00%
-100.0%
Q1 2019$817,239,000
+63.9%
57,674
+56.5%
0.00%
Q4 2018$498,540,000
-55.4%
36,847
-26.8%
0.00%
-100.0%
Q3 2018$1,117,511,000
+125.5%
50,361
+66.8%
0.00%
Q2 2018$495,549,00030,1980.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders